کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
327495 | 542907 | 2010 | 5 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: Association with dyskinetic movements Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: Association with dyskinetic movements](/preview/png/327495.png)
Several studies show that calcium-binding protein S100B is increased in schizophrenia and may be involved in the pathogenesis of tardive dyskinesia (TD). We therefore compared serum S100B levels in normal controls (n = 60), schizophrenic patients with (n = 32) and without TD (n = 50). Assessments included the abnormal involuntary movement scale (AIMS) and the positive and negative syndrome scale (PANSS). Serum S100B levels were measured by enzyme-linked immunosorbent assay (ELISA). The results indicated that patients with TD had higher serum S100B levels than normals and those without TD. Serum S100B levels were positively correlated with AIMS scores in patients with TD. These data suggest that increased S100B levels may be related to neuro-degeneration, associated with TD pathophysiology.
Journal: Journal of Psychiatric Research - Volume 44, Issue 7, May 2010, Pages 429–433